Cutler Group LP 180 Life Sciences Corp. Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	SELL	$2.53 - $3.9 $6,830 - $10,530	-2,700 Reduced 55.1%	2,200 $14,000
Q4 2021 Jan 18, 2022	SELL	$3.27 - $6.38 $41,202 - $80,388	-12,600 Reduced 72.0%	4,900 $37,000
Q3 2021 Oct 26, 2021	SELL	$5.11 - $10.81 $112,420 - $237,820	-22,000 Reduced 55.7%	17,500 $248,000
Q2 2021 Jul 19, 2021	BUY	$6.7 - $11.98 $236,510 - $422,894	35,300 Added 840.48%	39,500 $355,000
Q1 2021 Apr 26, 2021	BUY	$2.51 - $6.96 $10,542 - $29,232	4,200 New	4,200 $10,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $81.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.